Friday, September 21, 2012

Featured Event

Popular Event Types

September 2012
SMTWTFS
1
2345678
9101112131415
16171819202122
23242526272829
30
October 2012
SMTWTFS
123456
78910111213
14151617181920
21222324252627
28293031
       

Coronavirus News

The Simple Case Against the Newsom Autocracy | Capitol Quagmire

When the Michigan Supreme Court struck down that state’s Emergency Powers of the Governor Act as unconstitutional, it adopted the very arguments we are making in our case against Gov. Newsom.

COVID-19 and the Agendas to Come by James Perloff | Power of Prophecy

Drawing on statements of numerous scholars from around the world—virologists, epidemiologists, immunologists, pathologists, microbiologists, infectious disease specialists, including Nobel Prize winners, as well as front-line ER physicians and family practice MDs—veteran journalist James Perloff asks hard questions about the global response to COVID-19.

COVID19 PCR Tests are Scientifically Meaningless | OffGuardian

Lockdowns and hygienic measures around the world are based on numbers of cases and mortality rates created by the so-called SARS-CoV-2 RT-PCR tests used to identify “positive” patients, whereby “positive” is usually equated with “infected.” But looking closely at the facts, the conclusion is that these PCR tests are meaningless as a diagnostic tool to determine an alleged infection by a supposedly new virus called SARS-CoV-2.

‘Reliable result’: WHO hits back at Remdesivir developer after trial shows that drug failed to lower Covid-19 deaths | RT World News

The World Health Organization (WHO) has defended its study on Remdesivir after its developer argued that the results were "inconsistent" with previous studies. The WHO trial claimed that the drug doesn't help Covid-19 patients. “It's a reliable result, don't let anybody tell you otherwise, because they'll try to,” Richard Peto, an independent statistician hired by the WHO to evaluate its trial, told reporters on Friday. He argued that any benefits from Remdesivir may be due to chance, according to Reuters. The WHO-funded study of four antiviral drugs, including Remdesivir and Hydroxychloroquine, involved more than 11,000 Covid-19 patients in 30 countries. It found that all of the drugs tested had “little or no effect” on mortality, the need to be ventilated or the amount of days spent in a hospital.  Remdesivir's developer Gilead Sciences noted that the results of the trial have not been peer-reviewed and argued that they “appear inconsistent with more robust evidence from multiple randomized, controlled studies published in peer-reviewed journals.” The California-based company said that the benefits from Remdesivir for Covid-19 patients were demonstrated in three previous trials, the results of which were published in the New England Journal of Medicine last week.

CDC Study Finds Overwhelming Majority Of People Getting Coronavirus Wore Masks

A Centers for Disease Control report released in September shows that masks and face coverings are not effective in preventing the spread of COVID-19, even for those people who consistently wear them. A study conducted in the United States in July found that when they compared 154 “case-patients,” who tested positive for COVID-19, to a control group of 160 participants from the same health care facility who were symptomatic but tested negative, over 70 percent of the case-patients were contaminated with the virus and fell ill despite “always” wearing a mask. “In the 14 days before illness onset, 71% of case-patients and 74% of control participants reported always using cloth face coverings or other mask types when in public,” the report stated.

© 2020   Created by Ashland Source Center.   Powered by

Badges  |  Report an Issue  |  Terms of Service